Humans Have Antibodies against a Plant Virus: Evidence from Tobacco Mosaic Virus

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Liu, Ruolan ^a   Vaishnav, Radhika A ^a   Roberts, Andrew M ^a   Friedland, Robert P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; TOMM40L PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; MALE; MOLECULAR MIMICRY; NONHUMAN; PARKINSON DISEASE; SEQUENCE HOMOLOGY; SMOKELESS TOBACCO; SMOKING; TOBACCO; TOBACCO MOSAIC VIRUS;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; AUTOANTIBODIES; CROSS REACTIONS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PLANT DISEASES; SEQUENCE HOMOLOGY, AMINO ACID; SMOKING; TOBACCO; TOBACCO MOSAIC VIRUS; TOBACCO, SMOKELESS; YOUNG ADULT;

MAMMALIA; NICOTIANA TABACUM; TOBACCO MOSAIC VIRUS;

EID: 84875707654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060621     Document Type: Article

References (49)

1. Hu Q, Niu Y, Zhang K, Liu Y, Zhou X, (2011) Virus-derived transgenes expressing hairpin RNA give immunity to Tobacco mosaic virus and Cucumber mosaic virus. Virol J 8: 41.
2. Shriver LP, Koudelka KJ, Manchester M, (2009) Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection. J Neuroimmunol 211: 66-72.
3. Olszewska W, Steward MW, (2003) The molecular basis of the antigenic cross-reactivity between measles and cowpea mosaic viruses. Virology 310: 183-189.
4. Rae CS, Khor IW, Wang Q, Destito G, Gonzalez MJ, et al. (2005) Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 343: 224-235.
5. Colson P, Richet H, Desnues C, Balique F, Moal V, et al. (2010) Pepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humans. PLoS One 5: e10041.
6. Hymowitz N, (2011) Smoking and cancer: a review of public health and clinical implications. J Natl Med Assoc 103: 695-700.
7. Prochaska JJ, Hilton JF, (2012) Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ 344: e2856.
8. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, et al. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272: 1497-1505.
9. Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, et al. (2012) Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun.
10. Emre M, de Decker C, (1992) Effects of cigarette smoking on motor functions in patients with multiple sclerosis. Arch Neurol 49: 1243-1247.
11. Sopori M, (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377.
12. Arnson Y, Shoenfeld Y, Amital H, (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34: J258-265.
13. Rubin RL, Hermanson TM, Bedrick EJ, McDonald JD, Burchiel SW, et al. (2005) Effect of cigarette smoke on autoimmunity in murine and human systemic lupus erythematosus. Toxicol Sci 87: 86-96.
14. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S, (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81: 1462-1471.
15. Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, et al. (2008) Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord 23: 88-95.
16. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, et al. (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155: 732-738.
17. Chen H, Huang X, Guo X, Mailman RB, Park Y, et al. (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74: 878-884.
18. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, et al. (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64: 990-997.
19. Quik M, (2004) Smoking, nicotine and Parkinson's disease. Trends Neurosci 27: 561-568.
20. Quik M, Perez XA, Bordia T, (2012) Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov Disord 27: 947-957.
21. Liu R, La Cava A, Bai XF, Jee Y, Price M, et al. (2005) Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J Immunol 175: 7898-7904.
22. Mandal B, Jain RK, (2010) Can plant virus infect human being? Indian J Virol 21: 92-93.
23. Holzem A, Nahring JM, Fischer R, (2001) Rapid identification of a tobacco mosaic virus epitope by using a coat protein gene-fragment-pVIII fusion library. J Gen Virol 82: 9-15.
24. Carpenter CM, Le Clair RA, (1968) Tobacco mosaic virus and pulmonary diseases of humans. Dis Chest 54: 42-43.
25. Jefferis R, (1986) Human IgG subclass-specific epitopes recognised by murine monoclonal antibodies. Monogr Allergy 20: 26-33.
26. Bloomer AC, Champness JN, Bricogne G, Staden R, Klug A, (1978) Protein disk of tobacco mosaic virus at 2.8 A resolution showing the interactions within and between subunits. Nature 276: 362-368.
27. Altschuh D, Hartman D, Reinbolt J, Van Regenmortel MH, (1983) Immunochemical studies of tobacco mosaic virus--V. Localization of four epitopes in the protein subunit by inhibition tests with synthetic peptides and cleavage peptides from three strains. Mol Immunol 20: 271-278.
28. Westhof E, Altschuh D, Moras D, Bloomer AC, Mondragon A, et al. (1984) Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature 311: 123-126.
29. Moudallal ZA, Briand JP, Regenmortel MH, (1985) A major part of the polypeptide chain of tobacco mosaic virus protein is antigenic. EMBO J 4: 1231-1235.
30. Humphries AD, Streimann IC, Stojanovski D, Johnston AJ, Yano M, et al. (2005) Dissection of the mitochondrial import and assembly pathway for human Tom40. J Biol Chem 280: 11535-11543.
31. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, et al. (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 10: 375-384.
32. Jun G, Vardarajan BN, Buros J, Yu CE, Hawk MV, et al. (2012) Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region. Arch Neurol: 1-10.
33. Kimura A, Sakurai T, Yamada M, Koumura A, Hayashi Y, et al. (2012) Antibodies against the tom40 subunit of the translocase of the outer mitochondrial membrane complex and cognitive impairment in Alzheimer's disease. J Alzheimers Dis 29: 373-377.
34. Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, et al. (2012) A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta 1820: 553-564.
35. Croxford JL, Olson JK, Anger HA, Miller SD, (2005) Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J Virol 79: 8581-8590.
36. Chastain EM, Miller SD, (2012) Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev 245: 227-238.
37. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, et al. (2003) Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157: 1015-1022.
38. Schapira AH, (2012) Mitochondrial diseases. Lancet 379: 1825-1834.
39. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160.
40. Li WW, Yang R, Guo JC, Ren HM, Zha XL, et al. (2007) Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 18: 1543-1546.
41. Schwimmbeck PL, Dyrberg T, Drachman DB, Oldstone MB, (1989) Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest 84: 1174-1180.
42. Wucherpfennig KW, Strominger JL, (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
43. Tan EM, (2012) Autoantibodies, autoimmune disease, and the birth of immune diagnostics. J Clin Invest 122: 3835-3836.
44. Himoto T, Masaki T, (2012) Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol 2012: 871401.
45. Liu C, Zhao M, Jiang L, Cheng PN, Park J, et al. (2012) Out-of-register beta-sheets suggest a pathway to toxic amyloid aggregates. Proc Natl Acad Sci U S A 109: 20913-20918.
46. Sergeyeva TN, Sergeyev VG, Tolstolytskaya TO, (2011) Effects of bacterial endotoxin on alpha-synuclein expression in the lymph node leukocytes of rats. Bull Exp Biol Med 150: 348-351.
47. Friedland RP, Tedesco JM, Wilson AC, Atwood CS, Smith MA, et al. (2008) Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. J Biol Chem 283: 22550-22556.
48. Beraud D, Maguire-Zeiss KA, (2012) Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease. Parkinsonism Relat Disord 18Suppl 1: S17-20.
49. Folwarczna J, Moravec T, Plchova H, Hoffmeisterova H, Cerovska N, (2012) Efficient expression of Human papillomavirus 16 E7 oncoprotein fused to C-terminus of Tobacco mosaic virus (TMV) coat protein using molecular chaperones in Escherichia coli. Protein Expr Purif 85: 152-157.